Correlation Between Cathay Biotech and CNPC Capital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cathay Biotech and CNPC Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cathay Biotech and CNPC Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cathay Biotech and CNPC Capital Co, you can compare the effects of market volatilities on Cathay Biotech and CNPC Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cathay Biotech with a short position of CNPC Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cathay Biotech and CNPC Capital.

Diversification Opportunities for Cathay Biotech and CNPC Capital

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Cathay and CNPC is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Cathay Biotech and CNPC Capital Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CNPC Capital and Cathay Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cathay Biotech are associated (or correlated) with CNPC Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CNPC Capital has no effect on the direction of Cathay Biotech i.e., Cathay Biotech and CNPC Capital go up and down completely randomly.

Pair Corralation between Cathay Biotech and CNPC Capital

Assuming the 90 days trading horizon Cathay Biotech is expected to under-perform the CNPC Capital. But the stock apears to be less risky and, when comparing its historical volatility, Cathay Biotech is 1.1 times less risky than CNPC Capital. The stock trades about -0.37 of its potential returns per unit of risk. The CNPC Capital Co is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  728.00  in CNPC Capital Co on September 27, 2024 and sell it today you would lose (14.00) from holding CNPC Capital Co or give up 1.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Cathay Biotech  vs.  CNPC Capital Co

 Performance 
       Timeline  
Cathay Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cathay Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Cathay Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
CNPC Capital 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CNPC Capital Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, CNPC Capital sustained solid returns over the last few months and may actually be approaching a breakup point.

Cathay Biotech and CNPC Capital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cathay Biotech and CNPC Capital

The main advantage of trading using opposite Cathay Biotech and CNPC Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cathay Biotech position performs unexpectedly, CNPC Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CNPC Capital will offset losses from the drop in CNPC Capital's long position.
The idea behind Cathay Biotech and CNPC Capital Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance